2021
DOI: 10.1371/journal.pone.0255594
|View full text |Cite
|
Sign up to set email alerts
|

Primary care-based screening and management of depression amongst heavy drinking patients: Interim secondary outcomes of a three-country quasi-experimental study in Latin America

Abstract: Introduction Implementation of evidence-based care for heavy drinking and depression remains low in global health systems. We tested the impact of providing community support, training, and clinical packages of varied intensity on depression screening and management for heavy drinking patients in Latin American primary healthcare. Materials and methods Quasi-experimental study involving 58 primary healthcare units in Colombia, Mexico and Peru randomized to receive: (1) usual care (control); (2) training usin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 68 publications
0
7
0
Order By: Relevance
“…However, even if a patient is fully on-target for a drug, there is still a chance that the drug will not work well ( 41 , 42 ). Selective serotonin reuptake inhibitors (SSRIs) are often recommended as the antidepressant of choice ( 43 ), but 30–40% of patients do not respond adequately to the first prescribed antidepressant ( 44 ), this may be due to the patient’s genotype insensitive to SSRIs. Oestergaard et al ( 45 ) conducted a Delphi study on whether 5-HTTLPR polymorphism screening should be used in clinical problems of depression, expert opinion pointed out the impact of 5-HTTLPR pre-detection on clinical outcomes, the introduction of 5-HTTLPR genotyping will lead to 33.8, 48.2, 57.8, and 65.1% of patients reaching remission at 1, 2, 3, and 6 months, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…However, even if a patient is fully on-target for a drug, there is still a chance that the drug will not work well ( 41 , 42 ). Selective serotonin reuptake inhibitors (SSRIs) are often recommended as the antidepressant of choice ( 43 ), but 30–40% of patients do not respond adequately to the first prescribed antidepressant ( 44 ), this may be due to the patient’s genotype insensitive to SSRIs. Oestergaard et al ( 45 ) conducted a Delphi study on whether 5-HTTLPR polymorphism screening should be used in clinical problems of depression, expert opinion pointed out the impact of 5-HTTLPR pre-detection on clinical outcomes, the introduction of 5-HTTLPR genotyping will lead to 33.8, 48.2, 57.8, and 65.1% of patients reaching remission at 1, 2, 3, and 6 months, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…Previous evidence suggests that tailored interventions are more likely to have positive impact compared to generic approaches [ 43–46 ], and confirms the importance of involving community stakeholders in the development and delivery of alcohol prevention programmes [ 92 , 93 ]. Interim results from the wider SCALA study suggest that the tailored training package implemented in our intervention municipalities has led to increased coverage of alcohol measurement, and in turn depression screening, amongst PHC patients [ 80 , 94 ].…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, the following implementation strategies are included in the SCALA study: (1) provision of standard training combined with standard clinical package, e.g., clinical pathway and support materials (henceforth: standard training and clinical package); (2) provision of a more intensive training combined with a longer clinical package (henceforth: intensive training and clinical package); and (3) provision of community support. The strategies were compared to a control group, i.e., care as usual [ 22 , 23 ]. In each of the three participating countries, two municipalities were recruited (one without community support, and one with community support, see Table A1 for more information), each with 9–10 participating PHC centres (PHCC).…”
Section: Methodsmentioning
confidence: 99%